NutriBand (NTRB) Receivables - Net (2018 - 2026)
NutriBand (NTRB) posted Receivables - Net of $2632.0 for Q2 2026, down 97.78% sequentially from $118404.0 in Q1 2026, and down 97.2% YoY from $94136.0 in Q2 2025.
NutriBand (NTRB) Receivables - Net (2018 - 2026) Analysis & Trends
NutriBand has reported Receivables - Net for 9 years, with the latest figure at $2632.0 in Q2 2026.
- Quarterly Receivables - Net fell 97.2% year-over-year to $2632.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2632.0 (down 97.2% YoY) and the FY2026 annual result came in at $118404.0, up 11.15% from the prior year.
- Receivables - Net slipped to $2632.0 in Q2 2026 per NTRB's latest filing, from $118404.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $223452.0 in Q3 2023 and troughed at $2632.0 in Q2 2026.
- A 5-year average of $118723.2 and a median of $111337.5 in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2026: Receivables - Net surged 964.71% in 2022, then sank 97.2% in 2026.
- Over 5 years, Receivables - Net stood at $80455.0 in 2022, then surged by 110.89% to $169669.0 in 2023, then sank by 35.39% to $109630.0 in 2024, then surged by 34.6% to $147562.0 in 2025, then tumbled by 98.22% to $2632.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $2632.0, $118404.0, and $147562.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2,632.00 |
| Apr 30, 2026 | 2,632.00 |
| Jan 31, 2026 | 118,404.00 |
| Jan 31, 2026 | 118,404.00 |
| Oct 31, 2025 | 147,562.00 |
| Oct 31, 2025 | 147,562.00 |
| Jul 31, 2025 | 160,804.00 |
| Jul 31, 2025 | 160,804.00 |
| Apr 30, 2025 | 94,136.00 |
| Apr 30, 2025 | 94,136.00 |
| Jan 31, 2025 | 73,847.00 |
| Jan 31, 2025 | 73,847.00 |
| Oct 31, 2024 | 109,630.00 |
| Oct 31, 2024 | 109,630.00 |
| Jul 31, 2024 | 106,528.00 |
| Jul 31, 2024 | 106,528.00 |
| Apr 30, 2024 | 106,528.00 |
| Apr 30, 2024 | 106,528.00 |
| Jan 31, 2024 | 148,649.00 |
| Jan 31, 2024 | 148,649.00 |